With the support of funds and advanced equipment provided by Wuxi Municipal Government, Zheng Weiguo and the company's technicians successfully developed the first DNA detection kit in China at the end of 2007, found the "golden key" to reveal the origin of life, and passed the national appraisal and entered industrial production. With the rise of enterprises in China, the global market dominated by foreign biopharmaceutical giant Roche and American Applied Biosystems Company has changed, and the prices of similar products have dropped rapidly.
The company has established good cooperative relations with public security departments and paternity testing institutions in Beijing, Jiangsu, Jiangxi and other places, and its products are widely used in forensic medicine, clinical medicine, environmental protection and other fields. The company has applied for three invention patents for its nucleic acid detection technology. Therefore, Sino-German Midland Biotechnology Co., Ltd. has become a leading enterprise in the field of nucleic acid detection in China. In order to make this technology industrialized in China as soon as possible, the company, under the leadership of Dr. Zheng Weiguo, chairman and technical director, invested a lot of manpower and material resources in product research and development, and invested more than 4 million yuan in research and development expenses, including more than 3 million yuan in related instruments and equipment. Because Dr. Zheng Weiguo has been engaged in this technology research for many years in the United States, he has high-end technical level and rich research experience. At the same time, Jiangxi Sino-German Bioengineering Co., Ltd., one of the shareholder units, has also accumulated rich experience in the production of forensic DNA products and enterprise management, and basically solved the core technology of ABI Company's 3 10 and 3 130 sequencer consumables production. Thus, the monopoly position of foreign companies on testing equipment and consumables is overcome, and the research and development cost is greatly reduced. The product development process was completed six months ahead of schedule. At the product appraisal meeting held in Beijing in August 2008, experts including two academicians unanimously evaluated that the product technology reached the international advanced level.
At present, it has entered the stage of industrialization, and the public security systems in Beijing, Jiangxi and other places have begun to use its products. It is estimated that this year's sales will exceed 10 million yuan. Since its establishment, the company has received great help from all levels and departments. With this as the driving force, the company will completely replace imports by implementing the industrialization of products, realize the full localization of nucleic acid detection reagents, and promote the development of nucleic acid detection industry in China. The company will also strive to become a leading biotechnology enterprise with core independent intellectual property rights and industry competitiveness.